CytoSorbents reported preliminary unaudited revenue results for the fourth quarter full-year 2019. For the fourth quarter, total revenue was approximately $7.4 million versus $6.1 million a year ago. Growth accelerated in fourth quarter 2019, with quarterly unaudited product sales of approximately $6.6 million, a 21% increase versus $5.5 million a year ago, bolstered by a 30% increase in direct sales. 2019 unaudited total revenue was approximately $24.9 million versus $22.5 million in 2018. 2019 unaudited total product sales were approximately $22.8 million versus $20.3 million in 2018.